ALNY vs OMF · P/E 76, rev $1.29B vs P/E 8.7, rev $5.46B
Alnylam Pharmaceuticals Inc (ALNY) versus OneMain Holdings Inc (OMF) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
OneMain Holdings Inc (OMF) is a credit services company listed on NYSE.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported OMF revenue for 2025-12-31 was $5.46B. Net income was $783.0M. Revenue was up 9.3% from 2024-12-31 to 2025-12-31. OMF currently screens at market cap $6.75B and trailing P/E 8.7.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. OMF currently screens at market cap $6.75B and trailing P/E 8.7.
Not investment advice. Open the ALNY and OMF stock pages for the full models.
Not investment advice.